Global Health Press

Tag - WHO

GHP NewsLatest Science

Vaccines and vaccination news

Global WHO and public health WHO’s Technical Advisory Group on COVID-19 Vaccine Composition (TAG‑CO‑VAC) is preparing its next decision on updated COVID‑19 vaccine antigen composition, with a meeting scheduled for May...

14 April, 2026
4 min read
GHP NewsLatest Science

ViVa news – week 13

WHO kicks off World Immunization Week 2026 campaign messaging WHO has rolled out the 2026 World Immunization Week materials under a very on‑brand call to action: “Your decision makes a difference. Immunization for all,”...

2 April, 2026
12 min read
GHP NewsLatest Science

ViVa News – February 2026 Update

Regulatory, policy, and manufacturer news WHO influenza vaccine composition: WHO issued its recommendations for the 2026–2027 Northern Hemisphere seasonal influenza vaccine composition on 26 February 2026, including the...

5 March, 2026
5 min read
GHP NewsLatest Science

The global vaccine market 2024-2025

According to the WHO Global Vaccine Market Report 2024 and supporting financial data from major pharmaceutical rankings and peer-reviewed analyses, the following twelve companies accounted for the most global human...

21 October, 2025
5 min read
GHP NewsLatest Science

Vaccine manufacturer news

Western Companies Moderna (UK). Moderna has opened a new mRNA vaccine manufacturing facility in Oxfordshire, UK, with the capacity to produce approximately 100 million doses annually under steady-state conditions...

2 October, 2025
2 min read
GHP NewsLatest Science

Updates from and around WHO

Italy to leave IHR and WHO?  Shortly before the deadline, the Italian government officially rejected the World Health Organization’s (WHO) amendments to the International Health Regulations (IHR) concerning global...

23 July, 2025
4 min read